Wound-Healing Effects of Common Antineoplastic Agents and Perioperative Considerations for the Orthopaedic Surgeon
Authors:
- Joseph J. ConnollyJCJoseph J. Connolly
- Marcos R. GonzalezMGMarcos R. Gonzalez
- Santiago A. Lozano-CalderonSLSantiago A. Lozano-Calderon
- 2 May 2024
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of the American Academy of Orthopaedic Surgeons
- Vol. 32 (14) , e671-e682
Abstract
In oncologic patients, optimal postoperative wound healing is crucial for the maintenance of systemic therapies and improved survival. Although several risk factors for postoperative wound complications have been identified, the clinical effect of new antineoplastic agents on wound healing remains uncertain. The available literature on the effect of antineoplastic agents in wound healing is complex to analyze because of other confounding risk factors such as radiation therapy and certain patient-specific variables. Available perioperative drug recommendations are based on database opinion and case reports from adverse event alerts. This review highlights the characteristics of old and new antineoplastic agents commonly used in the treatment of sarcoma, carcinoma, and other cancers and their potential effects on the wound-healing process. It also aims to provide perioperative treatment cessation recommendations to guide orthopaedic surgeons and prevent drug-related wound complications to the fullest extent possible.Keywords
This publication has 38 references indexed in Scilit:
- Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children's Oncology Group and NRG OncologyJournal of Surgical Oncology, 2023
- Examining the relationship of immunotherapy and wound complications following flap reconstruction in patients with head and neck cancerHead & Neck, 2021
- Treatment and disease‐related complications in multiple myeloma: Implications for survivorshipAmerican Journal of Hematology, 2020
- Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedinCancer, 2019
- Risk factors for postoperative wound complications after extremity soft tissue sarcoma resection: A systematic review and meta-analysesJournal of Plastic, Reconstructive & Aesthetic Surgery, 2019
- Antiangiogenic activity of trabectedin in myxoid liposarcoma: Involvement of host TIMP‐1 and TIMP‐2 and tumor thrombospondin‐1International Journal of Cancer, 2014
- Effect of Tyrosine Kinase Inhibitors on Wound Healing and Tissue Repair: Implications for Surgery in Cancer PatientsDrug Safety, 2014
- Role of the antiangiogenetic drug paclitaxel on healing of intestinal anastomosis: an experimental studyTechniques in Coloproctology, 2005
- Optimal Timing for Surgery After Adriamycin Treatment in RatsSurgery Today, 2004
- Pharmacokinetics of intra-arterial and intravenous cisplatin in head and neck cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1986